Liza Cosca Villaruz

University Of Pittsburgh At Pittsburgh

$813,601

Attributed

$2,668,701

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $745.4K · FY2020–25

$1M$750K$500K$250K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,668,701 · 1

By mechanism

UM1$2,668,701 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Programs”

Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
Chanza Baytop · Westat, Inc.$271,217,917

Research focus

ProgramsLeadMemberUniversitiesComprehensive Cancer CenterLeadershipInvestigational TherapiesMalignant NeoplasmsPharmaceutical PreparationsEarly Therapeutic-Clinical Trials NetworkEnrollmentCatchment AreaEarly Phase Clinical TrialCancer CareCancer CenterClinical Trials NetworkDrug DevelopmentBiological MarkersClinical Drug DevelopmentDrug KineticsClinical DevelopmentCharacteristicsAlbert Einstein Cancer CenterCancer Therapy Evaluation Program

Grant awards (5)

NCI ETCTN Pittsburgh Cancer Consortium (PCC)$468,866

UM1 · FY2025 · CA · contact PI

NCI ETCTN Pittsburgh Cancer Consortium (PCC)$442,721

UM1 · FY2024 · CA · contact PI

NCI ETCTN Pittsburgh Cancer Consortium (PCC)$611,743

UM1 · FY2023 · CA

CATCH-UP: NCI ETCTN Pittsburgh Cancer Consortium (PCC)$400,000

UM1 · FY2022 · CA

NCI ETCTN Pittsburgh Cancer Consortium (PCC)$745,371

UM1 · FY2020 · CA